1. Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies;Andrade;Braz. J. Med. Biol. Res.,2016
2. Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies;Andrade;Braz. J. Med. Biol. Res.,2016
3. An FDA/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs);Avila;Regulatory Toxicol. Pharmacology: RTP,2020
4. Contemporary practices in core safety pharmacology assessments;Baird,2013
5. Central nervous system (CNS) safety pharmacology studies;Castagné,2013